1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
(
- Contribution to journal › Article
-
Mark
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
(
- Contribution to journal › Article
- 2022
-
Mark
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
(
- Contribution to journal › Article
- 2021
-
Mark
Imaging for precision medicine : can V-P SPECT measure mepolizumab response in asthma?
(
- Contribution to journal › Article
-
Mark
RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma
(
- Contribution to journal › Article
-
Mark
Patient perspectives on living with severe asthma in Denmark and Sweden
(
- Contribution to journal › Article
- 2020
-
Mark
International severe asthma registry (ISAR) : protocol for a global registry
(
- Contribution to journal › Article
- 2018
-
Mark
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma
(
- Contribution to journal › Article
- 2017
-
Mark
Role of biologics targeting type 2 airway inflammation in asthma : What have we learned so far?
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Immunopathological and Structural Alterations in Difficult to Control Asthma
(
- Thesis › Doctoral thesis (compilation)